000 | 01996 a2200625 4500 | ||
---|---|---|---|
005 | 20250513202743.0 | ||
264 | 0 | _c20000411 | |
008 | 200004s 0 0 eng d | ||
022 | _a0268-3369 | ||
024 | 7 |
_a10.1038/sj.bmt.1702136 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichel, D J | |
245 | 0 | 0 |
_aHighly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. _h[electronic resource] |
260 |
_bBone marrow transplantation _cFeb 2000 |
||
300 |
_a243-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xblood |
650 | 0 | 4 |
_aAntigens, CD34 _xblood |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xblood |
650 | 0 | 4 | _aCD4-CD8 Ratio |
650 | 0 | 4 | _aCell Survival |
650 | 0 | 4 | _aEquipment Failure |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunomagnetic Separation _xinstrumentation |
650 | 0 | 4 |
_aLeukapheresis _xstandards |
650 | 0 | 4 | _aLymphocyte Count |
650 | 0 | 4 |
_aMice _ximmunology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransplantation, Autologous _xadverse effects |
700 | 1 | _aJohnsen, H E | |
700 | 1 | _aCanon, J | |
700 | 1 | _aGuillaume, T | |
700 | 1 | _aSchaafsma, M R | |
700 | 1 | _aSchenkeveld, C | |
700 | 1 | _aHansen, S W | |
700 | 1 | _aMcNiece, I | |
700 | 1 | _aGringeri, A J | |
700 | 1 | _aBriddell, R | |
700 | 1 | _aEwen, C | |
700 | 1 | _aDavies, R | |
700 | 1 | _aFreeman, J | |
700 | 1 | _aMiltenyi, S | |
700 | 1 | _aSymann, M | |
773 | 0 |
_tBone marrow transplantation _gvol. 25 _gno. 3 _gp. 243-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702136 _zAvailable from publisher's website |
999 |
_c10628078 _d10628078 |